Title: BILLAS PASSED BY THE HOUSE H.293
Official Title: BILLAS PASSED BY THE HOUSE H.293
Number of Sections: 5
Source: versions - As Passed By the House (Official)
Media Type: application/pdf
Strikethrough Detection: 7 sections found

================================================================================

Section 1:
2025 Page 1 of 7
1 H.293
2 Introduced by Representative Maguire of Rutland City
3 Referred to Committee on
4 Date:
5 Subject: Health; health equity reporting; cancer registry; amyotrophic lateral
6 sclerosis registry; disclosure of identifying information
7 Statement of purpose of bill as introduced: This bill proposes to reduce from
8 annually to every three years the submission of a report by the Department of
9 Health analyzing health equity data. It further proposes to amend the
10 disclosure provisions pertaining to the cancer and amyotrophic lateral sclerosis
11 registries.
12 An act relating to health equity data reporting and registry disclosure
13 requirements
14 It is hereby enacted by the General Assembly of the State of Vermont:
15 * * * Health Equity Data Reporting * * *
16 Sec. 1. 18 V.S.A. § 253 is amended to read:
17 § 253. DATA RESPONSIVE TO HEALTH EQUITY INQUIRIES
18 * * *
19 (b)(1) The Department of Health shall systematically analyze such health
20 equity data using the smallest appropriate units of analysis feasible to detect
BILLAS PASSED BY THE HOUSE H.293
2025 Page 2 of 7
1 racial and ethnic disparities, as well as disparities along the lines of primary
2 language, sex, disability status, sexual orientation, gender identity, and
3 socioeconomic status, and report the results of such analysis on the
4 Department’s website periodically, but not less than biannually. The
5 Department’s analysis shall be used to measure over time the impact of actions
6 taken to reduce health disparities in Vermont. The data informing the
7 Department’s analysis shall be made available to the public in accordance with
8 State and federal law.
9 (2) Annually Every three years beginning in 2028, on or before January
10 15, the Department shall submit a report containing the results of the analysis
11 conducted pursuant to subdivision (1) of this subsection to the Senate
12 Committee on Health and Welfare and to the House Committees on Health
13 Care and on Human Services.
14 * * * Cancer Registry Disclosure Requirements * * *
15 Sec. 2. 18 V.S.A. § 155 is amended to read:
16 § 155. DISCLOSURE
17 * * *
18 (b) The Commissioner may furnish confidential information to the
19 National Breast and Cervical Cancer Early Detection Program, other states’
20 cancer registries, federal cancer control agencies, or health researchers in order
21 to collaborate in a national cancer registry or to collaborate in cancer control
BILLAS PASSED BY THE HOUSE H.293
2025 Page 3 of 7
1 and prevention research studies. However, before releasing confidential
2 information, the Commissioner shall first obtain from such state registries,
3 agencies, or researchers an agreement in writing to keep assurances acceptable
4 to the Commissioner that the identifying information shall be kept confidential
5 and privileged as required by law. In the case of researchers, the
6 Commissioner shall also first obtain evidence of the approval of their
7 academic committee for the protection of human subjects established in
8 accordance with 45 C.F.R. part 46 an institutional review board or privacy
9 board in accordance with 45 C.F.R. § 164.512(i)(1)(i)(A) and (B).
10 * * * Amyotrophic Lateral Sclerosis Registry Disclosure Requirements * * *
11 Sec. 3. 18 V.S.A. § 174 is amended to read:
12 § 174. CONFIDENTIALITY
13 (a)(1) All identifying information regarding an individual patient or health
14 care provider is exempt from public inspection and copying under the Public
15 Records Act and shall be kept confidential.
16 (2) Notwithstanding subdivision (1) of this subsection, the
17 Commissioner may enter into data sharing and protection agreements with
18 researchers or state, regional, or national amyotrophic lateral sclerosis
19 registries for bidirectional data exchange, provided access under such
20 agreements is consistent with the privacy, security, and disclosure protections
21 in this chapter. In the case of researchers, the Commissioner shall also first
BILLAS PASSED BY THE HOUSE H.293
2025 Page 4 of 7
1 obtain evidence of the approval of their academic committee for the protection
2 of human subjects established in accordance with 45 C.F.R. Part 46 an
3 institutional review board or privacy board in accordance with 45 C.F.R.
4 § 164.512(i)(1)(i)(A) and (B). The Commissioner shall disclose the minimum
5 information necessary to accomplish a specified research purpose.
6 * * *
7 * * * Effective Date * * *
8 Sec. 4. EFFECTIVE DATE
9 This act shall take effect on July 1, 2025.
* * * Health Equity Data Reporting * * *
Sec. 1. 18 V.S.A. § 253 is amended to read:

Section 2:
§ 253. DATA RESPONSIVE TO HEALTH EQUITY INQUIRIES
* * *
(b)(1) The Department of Health shall systematically analyze such health
equity data using the smallest appropriate units of analysis feasible to detect
racial and ethnic disparities, as well as disparities along the lines of primary
language, sex, disability status, sexual orientation, gender identity, and
socioeconomic status, and report the results of such analysis on the
Department’s website periodically, but not less than biannually. The
Department’s analysis shall be used to measure over time the impact of actions
taken to reduce health disparities in Vermont. The data informing the
BILLAS PASSED BY THE HOUSE H.293
2025 Page 5 of 7
Department’s analysis shall be made available to the public in accordance
with State and federal law.
(2) Annually Every three years beginning in 2028, on or before January
15, the Department shall submit a report containing the results of the analysis
conducted pursuant to subdivision (1) of this subsection to the Senate
Committee on Health and Welfare and to the House Committees on Health
Care and on Human Services.
* * * Cancer Registry Disclosure Requirements * * *
Sec. 2. 18 V.S.A. § 155 is amended to read:

Section 3:
§ 155. DISCLOSURE
* * *
(b) The Commissioner may furnish confidential information to the National
Breast and Cervical Cancer Early Detection Program, other states’ cancer
registries, federal cancer control agencies, or health researchers in order to
collaborate in a national cancer registry or to collaborate in cancer control
and prevention research studies. However, before releasing confidential
information, the Commissioner shall first obtain from such state registries,
agencies, or researchers an agreement in writing to keep written assurances
acceptable to the Commissioner that the identifying information shall be kept
confidential and privileged as required by law. In the case of researchers, the
Commissioner shall also first obtain written evidence of the approval of their
BILLAS PASSED BY THE HOUSE H.293
2025 Page 6 of 7
academic committee for the protection of human subjects established in
accordance with 45 C.F.R. part 46 an institutional review board or privacy
board in accordance with 45 C.F.R. § 164.512(i)(1)(i)(A) and (B).
* * * Amyotrophic Lateral Sclerosis Registry Disclosure Requirements * * *
Sec. 3. 18 V.S.A. § 174 is amended to read:

Section 4:
§ 174. CONFIDENTIALITY
(a)(1) All identifying information regarding an individual patient or health
care provider is exempt from public inspection and copying under the Public
Records Act and shall be kept confidential.
(2) Notwithstanding subdivision (1) of this subsection, the
Commissioner may enter into data sharing and protection agreements with
researchers or state, regional, or national amyotrophic lateral sclerosis
registries for bidirectional data exchange, provided access under such
agreements is consistent with the privacy, security, and disclosure protections
in this chapter. In the case of researchers, the Commissioner shall also first
obtain written evidence of the approval of their academic committee for the
protection of human subjects established in accordance with 45 C.F.R. Part 46
an institutional review board or privacy board in accordance with 45 C.F.R.

Section 5:
§ 164.512(i)(1)(i)(A) and (B). The Commissioner shall disclose the minimum
information necessary to accomplish a specified research purpose.
* * *
BILLAS PASSED BY THE HOUSE H.293
2025 Page 7 of 7
* * * Effective Date * * *
Sec. 4. EFFECTIVE DATE
This act shall take effect on July 1, 2025.
[DELETED: LASPDBYTEHEH5Pe1ofHIdbyReMeofRdCRdtoCeoDS:H;hheyr;crr;aclssr;deofigiStofpeofblasi:TsblpstorefaytoeyteystesnofartbyteDtoHhaghheyd.Itfrpstoadt0depspgtotecradaclls1r2Anatrgtohheydargadryd3r4ItishyedbyteGlAyofteSeofV5***HhEyDaRg**6S.1.18V.§3isadtor7§2.DARETOHHEYI8**9()TeDtofHhslsyaeshh0eydaugtestaeusofasfetod]
[DELETED: LASPDBYTEHEH5Pe2ofrladecd,aswlasdsagtelsofpl,s,dys,slo,gri,ascs,adrttersofshasontDswep,btntlstnb.TDsasslbeudtomeorteteitofatntorehhdsinV.TedaigtDsasslbemeaetotepcinaewSeadfll()AyEyteysbgin2,onorbeJ01,teDtslstartcgtersoftea1cdpttosn()oftssntoteS2CeonHhadWeadtoteHeCsonH3CeadonHnS4***CrRyDeRs**5S.2.18V.§5isadtor6§1.D7**8()TeCrmyfhclintot9NlBtadClCrEyDnP,ors0crr,flcrcla,orhhrsino1toceinanlcrryortoceincrc]
[DELETED: LASPDBYTEHEH5Pe3ofadpnrhs.H,bergci,teCrslftonfmshsera,orrsanatinwgtokpasatoteCrttteiginslbektcadpdasrdbyl.Inteceofr,tCrslaoftoneeoftealoftaccefrtepnofhnssediaewh45C.pt46anilrwbdorpbdinaewh45C.§)ad(0***AcLlSsRyDeRs**1S.3.18V.§4isadtor2§1.C3()Aliginrganilptorh4ceprisetfmpcinadcgurteP5RsAtadslbektc6()Ngsn()oftss,t7Crmyeriodasgadpnasw8rsors,r,ornlaclls9rsfrbldae,pdasurs0asisctwhtep,s,addep1intsc.Inteceofr,teCrslaof]
[DELETED: LASPDBYTEHEH5Pe4ofoneeoftealoftraccefrtepofhnssedinaewh45C.Pt46ailrwbdorpybdinaewh45C§)ad(.TeCrsldeteminnytoahasdrhp*****EeDe**S.4.EEDTsatslteetonJy1,2**HhEyDaRg**.1.18V.§3isadtor2.DARETOHHEYI*)TeDtofHhslsyaeshhydaugtestaeusofasfetodladecd,aswlasdsagtelsofp,s,dys,slo,gri,acs,adrttersofshasontswep,btntlstnb.TsasslbeudtomeorteteitofantorehhdsinV.Tedaigt]
[DELETED: LASPDBYTEHEH5Pe5ofsasslbemeaetotepcinahSeadfll)AyEyteysbgin2,onorbeJ,teDtslstartcgtersofteadpttosn()oftssntoteSeonHhadWeadtoteHeCsonHeadonHnS**CrRyDeRs**.2.18V.§5isadtor1.D*)TeCrmyfhclintoteNtadClCrEyDnP,ors’c,flcrcla,orhhrsinorteinanlcrryortoceincrcdpnrhs.H,bergc,teCrslftonfmshser,orrsanatinwgtokpwnaetoteCrttteiginslbekladpdasrdbyl.Inteceofr,trslaoftonwneeoftealoft]
[DELETED: LASPDBYTEHEH5Pe6ofccefrtepnofhnssediewh45C.pt46anilrwbdorpdinaewh45C.§)ad(**AcLlSsRyDeRs**.3.18V.§4isadtor1.C)AliginrganilptorheprisetfmpcinadcgurtePsAtadslbektc)Ngsn()oftss,trmyeriodasgadpnaswsors,r,ornlacllssfrbldae,pdasurssisctwhtep,s,addepntsc.Inteceofr,teCrslaofnwneeoftealoftraccefrtnofhnssedinaewh45C.Pt4nilrwbdorpybdinaewh45C)ad(.TeCrsldetemnnytoahasdrhp*]
[DELETED: LASPDBYTEHEH5Pe7of**EeDe**.4.EEDsatslteetonJy1,2]


================================================================================

Raw Text:
BILLAS PASSED BY THE HOUSE H.293
2025 Page 1 of 7
1 H.293
2 Introduced by Representative Maguire of Rutland City
3 Referred to Committee on
4 Date:
5 Subject: Health; health equity reporting; cancer registry; amyotrophic lateral
6 sclerosis registry; disclosure of identifying information
7 Statement of purpose of bill as introduced: This bill proposes to reduce from
8 annually to every three years the submission of a report by the Department of
9 Health analyzing health equity data. It further proposes to amend the
10 disclosure provisions pertaining to the cancer and amyotrophic lateral sclerosis
11 registries.
12 An act relating to health equity data reporting and registry disclosure
13 requirements
14 It is hereby enacted by the General Assembly of the State of Vermont:
15 * * * Health Equity Data Reporting * * *
16 Sec. 1. 18 V.S.A. § 253 is amended to read:
17 § 253. DATA RESPONSIVE TO HEALTH EQUITY INQUIRIES
18 * * *
19 (b)(1) The Department of Health shall systematically analyze such health
20 equity data using the smallest appropriate units of analysis feasible to detect

BILLAS PASSED BY THE HOUSE H.293
2025 Page 2 of 7
1 racial and ethnic disparities, as well as disparities along the lines of primary
2 language, sex, disability status, sexual orientation, gender identity, and
3 socioeconomic status, and report the results of such analysis on the
4 Department’s website periodically, but not less than biannually. The
5 Department’s analysis shall be used to measure over time the impact of actions
6 taken to reduce health disparities in Vermont. The data informing the
7 Department’s analysis shall be made available to the public in accordance with
8 State and federal law.
9 (2) Annually Every three years beginning in 2028, on or before January
10 15, the Department shall submit a report containing the results of the analysis
11 conducted pursuant to subdivision (1) of this subsection to the Senate
12 Committee on Health and Welfare and to the House Committees on Health
13 Care and on Human Services.
14 * * * Cancer Registry Disclosure Requirements * * *
15 Sec. 2. 18 V.S.A. § 155 is amended to read:
16 § 155. DISCLOSURE
17 * * *
18 (b) The Commissioner may furnish confidential information to the
19 National Breast and Cervical Cancer Early Detection Program, other states’
20 cancer registries, federal cancer control agencies, or health researchers in order
21 to collaborate in a national cancer registry or to collaborate in cancer control

BILLAS PASSED BY THE HOUSE H.293
2025 Page 3 of 7
1 and prevention research studies. However, before releasing confidential
2 information, the Commissioner shall first obtain from such state registries,
3 agencies, or researchers an agreement in writing to keep assurances acceptable
4 to the Commissioner that the identifying information shall be kept confidential
5 and privileged as required by law. In the case of researchers, the
6 Commissioner shall also first obtain evidence of the approval of their
7 academic committee for the protection of human subjects established in
8 accordance with 45 C.F.R. part 46 an institutional review board or privacy
9 board in accordance with 45 C.F.R. § 164.512(i)(1)(i)(A) and (B).
10 * * * Amyotrophic Lateral Sclerosis Registry Disclosure Requirements * * *
11 Sec. 3. 18 V.S.A. § 174 is amended to read:
12 § 174. CONFIDENTIALITY
13 (a)(1) All identifying information regarding an individual patient or health
14 care provider is exempt from public inspection and copying under the Public
15 Records Act and shall be kept confidential.
16 (2) Notwithstanding subdivision (1) of this subsection, the
17 Commissioner may enter into data sharing and protection agreements with
18 researchers or state, regional, or national amyotrophic lateral sclerosis
19 registries for bidirectional data exchange, provided access under such
20 agreements is consistent with the privacy, security, and disclosure protections
21 in this chapter. In the case of researchers, the Commissioner shall also first

BILLAS PASSED BY THE HOUSE H.293
2025 Page 4 of 7
1 obtain evidence of the approval of their academic committee for the protection
2 of human subjects established in accordance with 45 C.F.R. Part 46 an
3 institutional review board or privacy board in accordance with 45 C.F.R.
4 § 164.512(i)(1)(i)(A) and (B). The Commissioner shall disclose the minimum
5 information necessary to accomplish a specified research purpose.
6 * * *
7 * * * Effective Date * * *
8 Sec. 4. EFFECTIVE DATE
9 This act shall take effect on July 1, 2025.
* * * Health Equity Data Reporting * * *
Sec. 1. 18 V.S.A. § 253 is amended to read:
§ 253. DATA RESPONSIVE TO HEALTH EQUITY INQUIRIES
* * *
(b)(1) The Department of Health shall systematically analyze such health
equity data using the smallest appropriate units of analysis feasible to detect
racial and ethnic disparities, as well as disparities along the lines of primary
language, sex, disability status, sexual orientation, gender identity, and
socioeconomic status, and report the results of such analysis on the
Department’s website periodically, but not less than biannually. The
Department’s analysis shall be used to measure over time the impact of actions
taken to reduce health disparities in Vermont. The data informing the

BILLAS PASSED BY THE HOUSE H.293
2025 Page 5 of 7
Department’s analysis shall be made available to the public in accordance
with State and federal law.
(2) Annually Every three years beginning in 2028, on or before January
15, the Department shall submit a report containing the results of the analysis
conducted pursuant to subdivision (1) of this subsection to the Senate
Committee on Health and Welfare and to the House Committees on Health
Care and on Human Services.
* * * Cancer Registry Disclosure Requirements * * *
Sec. 2. 18 V.S.A. § 155 is amended to read:
§ 155. DISCLOSURE
* * *
(b) The Commissioner may furnish confidential information to the National
Breast and Cervical Cancer Early Detection Program, other states’ cancer
registries, federal cancer control agencies, or health researchers in order to
collaborate in a national cancer registry or to collaborate in cancer control
and prevention research studies. However, before releasing confidential
information, the Commissioner shall first obtain from such state registries,
agencies, or researchers an agreement in writing to keep written assurances
acceptable to the Commissioner that the identifying information shall be kept
confidential and privileged as required by law. In the case of researchers, the
Commissioner shall also first obtain written evidence of the approval of their

BILLAS PASSED BY THE HOUSE H.293
2025 Page 6 of 7
academic committee for the protection of human subjects established in
accordance with 45 C.F.R. part 46 an institutional review board or privacy
board in accordance with 45 C.F.R. § 164.512(i)(1)(i)(A) and (B).
* * * Amyotrophic Lateral Sclerosis Registry Disclosure Requirements * * *
Sec. 3. 18 V.S.A. § 174 is amended to read:
§ 174. CONFIDENTIALITY
(a)(1) All identifying information regarding an individual patient or health
care provider is exempt from public inspection and copying under the Public
Records Act and shall be kept confidential.
(2) Notwithstanding subdivision (1) of this subsection, the
Commissioner may enter into data sharing and protection agreements with
researchers or state, regional, or national amyotrophic lateral sclerosis
registries for bidirectional data exchange, provided access under such
agreements is consistent with the privacy, security, and disclosure protections
in this chapter. In the case of researchers, the Commissioner shall also first
obtain written evidence of the approval of their academic committee for the
protection of human subjects established in accordance with 45 C.F.R. Part 46
an institutional review board or privacy board in accordance with 45 C.F.R.
§ 164.512(i)(1)(i)(A) and (B). The Commissioner shall disclose the minimum
information necessary to accomplish a specified research purpose.
* * *

BILLAS PASSED BY THE HOUSE H.293
2025 Page 7 of 7
* * * Effective Date * * *
Sec. 4. EFFECTIVE DATE
This act shall take effect on July 1, 2025.

[DELETED: LASPDBYTEHEH5Pe1ofHIdbyReMeofRdCRdtoCeoDS:H;hheyr;crr;aclssr;deofigiStofpeofblasi:TsblpstorefaytoeyteystesnofartbyteDtoHhaghheyd.Itfrpstoadt0depspgtotecradaclls1r2Anatrgtohheydargadryd3r4ItishyedbyteGlAyofteSeofV5***HhEyDaRg**6S.1.18V.§3isadtor7§2.DARETOHHEYI8**9()TeDtofHhslsyaeshh0eydaugtestaeusofasfetod]
[DELETED: LASPDBYTEHEH5Pe2ofrladecd,aswlasdsagtelsofpl,s,dys,slo,gri,ascs,adrttersofshasontDswep,btntlstnb.TDsasslbeudtomeorteteitofatntorehhdsinV.TedaigtDsasslbemeaetotepcinaewSeadfll()AyEyteysbgin2,onorbeJ01,teDtslstartcgtersoftea1cdpttosn()oftssntoteS2CeonHhadWeadtoteHeCsonH3CeadonHnS4***CrRyDeRs**5S.2.18V.§5isadtor6§1.D7**8()TeCrmyfhclintot9NlBtadClCrEyDnP,ors0crr,flcrcla,orhhrsino1toceinanlcrryortoceincrc]
[DELETED: LASPDBYTEHEH5Pe3ofadpnrhs.H,bergci,teCrslftonfmshsera,orrsanatinwgtokpasatoteCrttteiginslbektcadpdasrdbyl.Inteceofr,tCrslaoftoneeoftealoftaccefrtepnofhnssediaewh45C.pt46anilrwbdorpbdinaewh45C.§)ad(0***AcLlSsRyDeRs**1S.3.18V.§4isadtor2§1.C3()Aliginrganilptorh4ceprisetfmpcinadcgurteP5RsAtadslbektc6()Ngsn()oftss,t7Crmyeriodasgadpnasw8rsors,r,ornlaclls9rsfrbldae,pdasurs0asisctwhtep,s,addep1intsc.Inteceofr,teCrslaof]
[DELETED: LASPDBYTEHEH5Pe4ofoneeoftealoftraccefrtepofhnssedinaewh45C.Pt46ailrwbdorpybdinaewh45C§)ad(.TeCrsldeteminnytoahasdrhp*****EeDe**S.4.EEDTsatslteetonJy1,2**HhEyDaRg**.1.18V.§3isadtor2.DARETOHHEYI*)TeDtofHhslsyaeshhydaugtestaeusofasfetodladecd,aswlasdsagtelsofp,s,dys,slo,gri,acs,adrttersofshasontswep,btntlstnb.TsasslbeudtomeorteteitofantorehhdsinV.Tedaigt]
[DELETED: LASPDBYTEHEH5Pe5ofsasslbemeaetotepcinahSeadfll)AyEyteysbgin2,onorbeJ,teDtslstartcgtersofteadpttosn()oftssntoteSeonHhadWeadtoteHeCsonHeadonHnS**CrRyDeRs**.2.18V.§5isadtor1.D*)TeCrmyfhclintoteNtadClCrEyDnP,ors’c,flcrcla,orhhrsinorteinanlcrryortoceincrcdpnrhs.H,bergc,teCrslftonfmshser,orrsanatinwgtokpwnaetoteCrttteiginslbekladpdasrdbyl.Inteceofr,trslaoftonwneeoftealoft]
[DELETED: LASPDBYTEHEH5Pe6ofccefrtepnofhnssediewh45C.pt46anilrwbdorpdinaewh45C.§)ad(**AcLlSsRyDeRs**.3.18V.§4isadtor1.C)AliginrganilptorheprisetfmpcinadcgurtePsAtadslbektc)Ngsn()oftss,trmyeriodasgadpnaswsors,r,ornlacllssfrbldae,pdasurssisctwhtep,s,addepntsc.Inteceofr,teCrslaofnwneeoftealoftraccefrtnofhnssedinaewh45C.Pt4nilrwbdorpybdinaewh45C)ad(.TeCrsldetemnnytoahasdrhp*]
[DELETED: LASPDBYTEHEH5Pe7of**EeDe**.4.EEDsatslteetonJy1,2]